Pfizer concocts a ‘deal from hell’

Buying AstraZeneca would be bad for everyone except the CEO, writes Howard Gold.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.